Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Qualis Innovations Inc (PK) | QLIS | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.2601 | 0.2601 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.25 - 1.0101 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.2601 | USD |
Qualis Innovations Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.2M | 8.44M | - | 94k | -921k | -0.11 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Qualis Innovations (PK) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QLIS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.2631 | 0.2631 | 0.2601 | 0.2628853 | 1,770 | -0.003 | -1.14% |
1 Month | 0.313 | 0.32 | 0.2601 | 0.2660048 | 800 | -0.0529 | -16.90% |
3 Months | 0.2601 | 0.32 | 0.2601 | 0.2652196 | 444 | 0.00 | 0.00% |
6 Months | 0.30 | 0.7499 | 0.2601 | 0.337951 | 353 | -0.0399 | -13.30% |
1 Year | 0.561 | 1.0101 | 0.25 | 0.654495 | 507 | -0.3009 | -53.64% |
3 Years | 0.60 | 4.90 | 0.0251 | 1.56 | 432 | -0.3399 | -56.65% |
5 Years | 1.00 | 4.90 | 0.0251 | 1.33 | 453 | -0.7399 | -73.99% |
Qualis Innovations (PK) Description
Qualis Innovations, Inc. is the holding company of mPathix Health, Inc. ("mPathix). mPathix is focused on the development, production and distribution of multi-modal pain management and CNS-related solutions. We are a clinical stage company, developing innovative pain management products using a modality agnostic, virtual operating model. mPathix's lead product under development is the SOLACE electromagnetic induction device, which was originally cleared by the FDA for treatment of selected medical conditions such as relief of pain, muscle spasms, and joint contractures, but not for the treatment of malignancies. |